Ghulam Mufti

10.7k total citations · 2 hit papers
101 papers, 5.8k citations indexed

About

Ghulam Mufti is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Ghulam Mufti has authored 101 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 27 papers in Immunology and 23 papers in Genetics. Recurrent topics in Ghulam Mufti's work include Acute Myeloid Leukemia Research (40 papers), Hematopoietic Stem Cell Transplantation (24 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Ghulam Mufti is often cited by papers focused on Acute Myeloid Leukemia Research (40 papers), Hematopoietic Stem Cell Transplantation (24 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Ghulam Mufti collaborates with scholars based in United Kingdom, Japan and France. Ghulam Mufti's co-authors include David Oscier, John M. Bennett, Pierre Fenaux, Christopher Cox, Carlo Aul, Terry J. Hamblin, Guillermo Sanz, Miguel Á. Sanz, Teresa Vallespı́ and Michelle M. LeBeau and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Ghulam Mufti

94 papers receiving 5.7k citations

Hit Papers

International Scoring Sys... 1997 2026 2006 2016 1997 2015 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ghulam Mufti United Kingdom 27 4.7k 2.0k 1.2k 886 818 101 5.8k
Ulrich Germing Germany 37 5.4k 1.1× 2.4k 1.2× 2.4k 2.0× 824 0.9× 804 1.0× 252 7.0k
Guido Kobbe Germany 40 3.8k 0.8× 1.3k 0.7× 1.1k 0.9× 961 1.1× 1.3k 1.6× 204 5.2k
Ulrike Bacher Germany 39 4.1k 0.9× 2.1k 1.1× 1.8k 1.5× 764 0.9× 1.1k 1.3× 281 5.7k
F Bauters France 45 5.2k 1.1× 3.0k 1.6× 2.6k 2.1× 571 0.6× 1.4k 1.7× 211 7.3k
Donald Milligan United Kingdom 40 4.5k 0.9× 2.1k 1.1× 2.0k 1.7× 1.1k 1.2× 1.6k 2.0× 99 6.7k
Petra Muus Netherlands 37 3.3k 0.7× 1.4k 0.7× 1.2k 1.0× 2.6k 2.9× 649 0.8× 176 5.8k
Nicolas Boissel France 42 3.6k 0.8× 1.2k 0.6× 2.0k 1.7× 1000 1.1× 1.5k 1.8× 200 6.1k
Austin Kulasekararaj United Kingdom 35 3.3k 0.7× 1.5k 0.8× 880 0.7× 2.1k 2.3× 579 0.7× 207 5.1k
Vinod Pullarkat United States 38 3.8k 0.8× 1.4k 0.7× 1.9k 1.6× 865 1.0× 1.2k 1.4× 228 6.0k
M Körbling United States 35 4.0k 0.8× 1.3k 0.7× 599 0.5× 1.5k 1.7× 1.8k 2.2× 102 5.4k

Countries citing papers authored by Ghulam Mufti

Since Specialization
Citations

This map shows the geographic impact of Ghulam Mufti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghulam Mufti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghulam Mufti more than expected).

Fields of papers citing papers by Ghulam Mufti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghulam Mufti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghulam Mufti. The network helps show where Ghulam Mufti may publish in the future.

Co-authorship network of co-authors of Ghulam Mufti

This figure shows the co-authorship network connecting the top 25 collaborators of Ghulam Mufti. A scholar is included among the top collaborators of Ghulam Mufti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghulam Mufti. Ghulam Mufti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulasekararaj, Austin, Jamie Cavenagh, Inderjeet Dokal, et al.. (2024). Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline. British Journal of Haematology. 204(3). 784–804. 35 indexed citations
2.
Killick, Sally, Wendy Ingram, Dominic Culligan, et al.. (2021). British Society for Haematology guidelines for the management of adult myelodysplastic syndromes. British Journal of Haematology. 194(2). 267–281. 14 indexed citations
3.
Alimam, Samah, Richard Dillon, Michael A. Simpson, et al.. (2021). Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Advances. 5(4). 1059–1068. 14 indexed citations
4.
Sheth, Vipul, Victoria Potter, Hugues de Lavallade, et al.. (2021). Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study. Blood Cancer Journal. 11(7). 5 indexed citations
5.
Killick, Sally, Daniel H. Wiseman, Lynn Quek, et al.. (2021). British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes. British Journal of Haematology. 194(2). 282–293. 5 indexed citations
6.
Bono, Elisa, Donal P. McLornan, Erica Travaglino, et al.. (2017). Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization. Blood. 130. 588–588. 1 indexed citations
7.
Smith, Alexander, Tala Shahin, Austin Kulasekararaj, et al.. (2017). Neoantigens in MDS Are Associated with Two Novel CD4+ T Cell Subsets and Improved Overall Survival. Blood. 130. 2958–2958. 3 indexed citations
10.
Santini, Valeria, Ari Melnick, Jaroslaw P. Maciejewski, et al.. (2013). Epigenetics in focus: Pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents. Critical Reviews in Oncology/Hematology. 88(2). 231–245. 27 indexed citations
11.
Jiang, Jie, Daryl Cole, Nigel Westwood, et al.. (2010). Crucial Roles for Protein Kinase C Isoforms in Tumor-Specific Killing by Apoptin. Cancer Research. 70(18). 7242–7252. 27 indexed citations
12.
Westbrook, Rachel, David Orr, Nigel Heaton, et al.. (2010). Predicting Thrombotic Complications after Liver Transplantation in Patients with Budd Chiari Syndrome. Research Portal (King's College London). 16(6). 2 indexed citations
13.
Brooks, Suzanne, Matthew Arno, H-G Rammensee, et al.. (2009). Identification of a novel cancer-testis antigen as a target for the immunotherapy of acute myeloid leukaemia (AML). 145. 19–19. 1 indexed citations
14.
Martin, Andrew, et al.. (2006). Hydroxyurea Treatment of Meningiomas: A Pilot Study. Skull base. 16(3). 157–160. 28 indexed citations
15.
Lim, ZiYi, Ronald Brand, Anja van Biezen, et al.. (2006). Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myelodysplastic Syndromes 50 Years or Older. A Retrospective Survey from the EBMT.. Blood. 108(11). 520–520. 1 indexed citations
17.
Soeiro, Inês, Nicholas Lea, Janet Glassford, et al.. (2003). Cyclin D2 controls B cell progenitor numbers.. Research Portal (King's College London). 102(11). 1 indexed citations
18.
Duncan, Edward, Kavita Raj, & Ghulam Mufti. (2003). Erythema following imatinib mesylate. British Journal of Haematology. 122(1). 1–1. 13 indexed citations
19.
Lea, Nicholas, et al.. (1999). Gene expression using adenoviral vectors in primary acute myeloid leukaemia cells.. Research Portal (King's College London). 94(10). 1 indexed citations
20.
Ireland, Robin, D.J. Gillett, Giorgina Mieli‐Vergani, & Ghulam Mufti. (1988). Pre-ALL and Non-A, Non-B hepatitis infection. Leukemia Research. 12(10). 795–797. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026